Medical A/R Recovery Services

A recovery service helps identify and pursue unpaid, underpaid, delayed, or incorrectly processed claims and balances. In medical A/R, that can include aging claim follow-up, denial review, payment reconciliation, appeal support, and investigation of revenue leakage. For infectious disease practices, recovery work may involve E/M services, infusion administration, drug claims, OPAT, hospital consults, and payer or benefit issues.

Medical A/R can include aging E/M claims, hospital consult claims, infusion administration claims, drug claims, and other outpatient balances. A useful review organizes receivables by payer, service type, and balance, then examines why each claim stalled. The findings can help distinguish unresolved follow-up from broader issues involving coding, documentation, authorization, charge capture, payment application, or contract compliance.

Denial management identifies the reason claims were rejected or unpaid, groups recurring causes, and supports payer-specific appeals. Infectious disease denials may involve drug and administration coding, missing authorization, medical versus pharmacy benefit confusion, or under-documented consults. Reviewing the root cause alongside the appeal process can help practices address problems with clinical documentation, coding, front-office workflows, and payer requirements.

Yes. Payment reconciliation compares received payments with expected reimbursement for drug, administration, and E/M claims. The review can flag short-pays, incorrect fee schedule application, unit mismatches, NDC mismatches, or other differences requiring investigation. Documented findings can then support disputes and recovery while showing whether payment problems are isolated or connected to broader payer, billing, or contract issues.

Revenue leakage can begin before a claim is submitted through under-leveled visits, missed drug or administration charges, incomplete documentation, authorization gaps, or unpursued balances. It can also appear after submission through denials, underpayments, benefit confusion, or contract noncompliance. Reviewing reporting by payer, service line, and provider helps connect the missing revenue to its operational source.

Claims follow-up is a central part of A/R recovery. It involves reviewing aging claims by payer, service type, and balance, documenting each follow-up action, and continuing investigation until the claim is resolved or the next action is clear. For infectious disease practices, special attention may be appropriate for high-value drug and infusion claims, hospital consults, and complex outpatient services.

Yes. GrowInfectiousDisease is designed to help practices apply their own numbers rather than rely on generalized rates, margins, drug acquisition costs, or payment assumptions. Using practice-specific information can make a review more relevant to the services, payer mix, workflows, and operational decisions under consideration, while the resource maintains a clear distinction between verified facts and unknown figures.

Yes. The guidance is tailored to the economics and operational structure of independent infectious disease practices. It addresses service lines and issues such as OPAT, infusion, buy-and-bill, reimbursement, coverage agreements, staffing, denials, underpayments, authorization, and revenue cycle management. The intended audience includes infectious disease physicians, independent practices, group leaders, and medical practice administrators.